Milestone Pharmaceuticals Files 8-K
Ticker: MIST · Form: 8-K · Filed: Jun 16, 2025 · CIK: 1408443
Sentiment: neutral
Topics: reporting, corporate-filing
TL;DR
Milestone Pharma filed an 8-K on 6/16/25. Standard reporting.
AI Summary
Milestone Pharmaceuticals Inc. filed an 8-K on June 16, 2025, reporting other events and financial statements. The company, incorporated in Quebec with its principal executive offices in Montreal, operates in the pharmaceutical preparations industry.
Why It Matters
This filing indicates routine corporate activity and financial reporting for Milestone Pharmaceuticals Inc., providing transparency to investors about the company's status.
Risk Assessment
Risk Level: low — This is a routine filing for a public company and does not appear to contain any significant new risks or material events.
Key Players & Entities
- Milestone Pharmaceuticals Inc. (company) — Registrant
- June 16, 2025 (date) — Date of earliest event reported
- Montreal (location) — City of principal executive offices
- Quebec (location) — State/Jurisdiction of incorporation
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing is for Milestone Pharmaceuticals Inc. to report 'Other Events' and 'Financial Statements and Exhibits'.
When was the earliest event reported in this filing?
The date of the earliest event reported is June 16, 2025.
Where are Milestone Pharmaceuticals Inc.'s principal executive offices located?
The principal executive offices are located at 1111 Dr. Frederik-Philips Boulevard, Suite 420, Montréal, Québec, H4M 2X6.
What is Milestone Pharmaceuticals Inc.'s telephone number?
The company's telephone number, including area code, is (514) 336-0444.
In which jurisdiction was Milestone Pharmaceuticals Inc. incorporated?
Milestone Pharmaceuticals Inc. was incorporated in Québec.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 16, 2025 regarding Milestone Pharmaceuticals Inc. (MIST).